MITOPOWER LLC
Therapeutics for patients with severe mitochondrial dysfunction
East Palo Alto, United States · Founded 2021
- Headquarters
- East Palo Alto, California
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- mitopower.com
- Last Round
- GrantJan 2021
- Rounds
- 1
About
MitoPower is a biopharmaceutical company developing novel therapies for disorders associated with mitochondrial dysfunction, with a focus on liver and metabolic diseases. Their lead candidate MP-04 is a small molecule that enhances mitochondrial function, currently in pre-clinical development for alcoholic liver disease-associated hepatorenal syndrome (HRS). The company received a $6.5M NIH SBIR grant in collaboration with the University of Maryland Institute of Human Virology.
Summary
MITOPOWER LLC is a Biotech company based in East Palo Alto, United States, founded in 2021. Its most recent funding was a Grant round in Jan 2021. Investors include National Cancer Institute.
Funding History
Jan 2021
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mitopower-llc"><img src="https://indexed.vc/api/badge/company/mitopower-llc" alt="MITOPOWER LLC on Indexed.vc" width="260" height="76" /></a>